12 / 18
Page 40
Day 2 September 13, 2016
Session Chair
Reza Nassiri
Michigan State University, USA
Session Co-Chair
Hanna Radecka
Polish Academy of Science, Poland
Tracks: 2,6,10 & 11
Track 2: Pathogenicity of Influenza Virus
Track 6:Antiviral Drug Development and Treatment Strategies, Including
Vaccination
Track 10: Influenza Lung Immunology: Major Aspects
Track 11: Animal Flu-Ecology
Session Introduction
Title:
Influenza in Russia in 2014-2016
Tatyana Ilyicheva,
Vector State Research Center of Virology and Biotechnology, Russia
Title:
Kallikrein-related peptidase 5 contributes to H3N2 influenza virus infection in human lungs
Melia Magnen,
Institut National de la Santé et de la Recherche Médicale, France
Title:
The clinical characteristics and outcome of H1N1 pneumonia patients with and without acute renal
injury
Essam Saad Abdel Rahim Badawy,
Minia University, Egypt
Title:
Types of human influenza virus among patient at Abubakar Tafawa Balewa University Teaching
Hospital (ATBUTH), Bauchi, Nigeria
Jacob A Dunga,
ATBU Teaching Hospital, Nigeria
Title:
Study on the circulation of influenza A virus in swine populations in Kazakhstan
Nailya Klivleyeva,
Institute of Microbiology and Virology, Kazakhstan
Title:
Herbal immune boosters: Valuable preventive means for international travelers flu
Mohammad Ali Daneshmehr,
Iran University of Mediccal Sciences, Iran